Türkiye Inflation Rises to 67%, Keeping Pressure on Cenbank

A full moon rises behind the Camlica mosque in Istanbul, Türkiye, Saturday, Feb. 24, 2024. (AP Photo/Emrah Gurel)
A full moon rises behind the Camlica mosque in Istanbul, Türkiye, Saturday, Feb. 24, 2024. (AP Photo/Emrah Gurel)
TT

Türkiye Inflation Rises to 67%, Keeping Pressure on Cenbank

A full moon rises behind the Camlica mosque in Istanbul, Türkiye, Saturday, Feb. 24, 2024. (AP Photo/Emrah Gurel)
A full moon rises behind the Camlica mosque in Istanbul, Türkiye, Saturday, Feb. 24, 2024. (AP Photo/Emrah Gurel)

Türkiye's annual inflation rate climbed to 67.07% in February, exceeding expectations and keeping up pressure for tight monetary policy amid strong rises in food, hotel and education prices, official data showed on Monday.
Shortly before the data, Finance Minister Mehmet Simsek told local broadcaster BloombergHT that inflation would remain high in the coming months due to base effects and the delayed impact of rate hikes, but would fall in the next 12 months.
The central bank has hiked interest rates by 3,650 basis points since June, but has now paused its tightening cycle saying that the current 45% policy rate is sufficient to bring inflation down, Reuters said.
Yet some economists see a growing prospect of more tightening sometime after nationwide local elections on March 31, given the price pressure and
strong domestic demand.
"Core price pressures continue to run hot and if this continues, the possibility of a restart to the central bank's tightening cycle will only increase in the coming months," said Capital Economics senior emerging markets economist Liam Peach.
Month-on-month consumer price inflation (CPI) was 4.53%, according to the Turkish Statistical Institute, down from 6.70% in January but well above a Reuters poll forecast of 3.7%.
Annual inflation was expected to climb to 65.7% in February before falling to 42.7% by the end of 2024, the poll found.
In January, annual consumer price inflation was 64.86%.
"Inflation was high in January due to temporary effects. There could be some continuation of that in February," Simsek said. "However as of March, inflation will be back on trend. It will become in line with our disinflation path."
LIRA SLIDE
The lira has weakened 6% this year after a near-37% slide in 2023, further stoking import prices. It was slightly weaker at 31.4205 against the dollar after the data.
Though some analysts predict currency weakness after the elections - in which President Tayyip Erdogan's ruling party seeks to reclaim big cities from the opposition - Simsek said authorities want neither a depreciating nor very valuable lira.
Restaurants and hotels led the price rises in February, surging 94.5%, followed by a 91.8% rise in education prices. Heavily weighted food and non-alcoholic drinks prices jumped 71.1%.
Economists have said that February inflation was also driven by the lingering impact of this year's minimum wage hike on the services sector.
Last month, the central bank maintained its 36% year-end inflation target and vowed to keep policy tight for longer to bring inflation down to the forecasted path. The Reuters poll showed annual inflation falling only to 42.7% by year end.
The domestic producer price index was up 3.74% month-on-month in February for an annual rise of 47.29%, the data showed.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.